Prelude Capital Management, LLC Dr Reddys Laboratories LTD Transaction History
Prelude Capital Management, LLC
- $1.5 Billion
- Q4 2024
A detailed history of Prelude Capital Management, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Prelude Capital Management, LLC holds 39,836 shares of RDY stock, worth $514,681. This represents 0.04% of its overall portfolio holdings.
Number of Shares
39,836
Previous 11,363
250.58%
Holding current value
$514,681
Previous $902,000
30.27%
% of portfolio
0.04%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding RDY
# of Institutions
264Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$148 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$145 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$130 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$122 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$72.5 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.15B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...